Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07431840 · ClinicalTrials.gov registry record · NA
Immune Defense Protein Impact On Respiratory Immune Outcomes
A NA study of Influenza and Viral Upper Respiratory Infection, sponsored by Quantec.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT07431840 is a NA study of Influenza and Viral Upper Respiratory Infection that is actively recruiting participants, run by Quantec. The registered enrollment target is 300 participants, below the 36,802-participant average among 156 other Influenza trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07431840, a NA study of Influenza and Viral Upper Respiratory Infection, is actively recruiting participants, sponsored by Quantec.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary goal of this study is to observe the impact of the IDP® Supplement on the duration and severity of upper respiratory symptoms in older individuals during the cold and flu season. Secondary aims include observing the product's effect on rescue medication use, quality of life, and overall tolerability. This is conducted as a consumer-driven, decentralized observational clinical research study in adults aged 60 or older, using self-reported measures and questionnaires completed at home via the Chloe App.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Immune Defense Protein 50mg Dose
- DIETARY_SUPPLEMENT IDP 200mg Dose
- DIETARY_SUPPLEMENT Matching Placebo
Study Locations (1)
California
- People Science, Inc. - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-12-05 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07431840
The ClinicalTrials.gov registry entry for NCT07431840 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 36,802-participant average among 156 other Influenza trials with a reported enrollment target (99% lower). The listed sponsor is Quantec, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Influenza appearing as the primary indexed condition, and to 3 interventions - of which Immune Defense Protein 50mg Dose is the first listed.
NCT07431840 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT07431840 about?
NCT07431840 is a clinical study titled "Immune Defense Protein Impact On Respiratory Immune Outcomes". The primary goal of this study is to observe the impact of the IDP® Supplement on the duration and severity of upper respiratory symptoms in older individuals during the cold and flu season. Secondary aims include observing the product's effect on rescue medication use, quality of life, and overall ...
What is the current status of trial NCT07431840?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2025-12-05. Estimated completion is 2026-07-31.
What conditions does trial NCT07431840 study?
This clinical trial studies the following conditions: Influenza, Viral Upper Respiratory Infection, Upper Respiratory Disease.
What interventions are being tested in trial NCT07431840?
The interventions under investigation include: Immune Defense Protein 50mg Dose (DIETARY_SUPPLEMENT), IDP 200mg Dose (DIETARY_SUPPLEMENT), Matching Placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07431840?
This trial is sponsored by Quantec, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07431840 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Influenza
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Influenza Immunization in Adults Over Age 75
RECRUITING · NA
-
H5N1 Milk Detection Study
RECRUITING · NA
-
Dime La VerDAD: Verify, Debunk, and Disseminate
RECRUITING · NA
-
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
RECRUITING · NA
-
Impact of High Dietary Fiber on Microbiome and Vaccine Responses
ACTIVE NOT RECRUITING · NA
-
Exercise and COVID-19 Viral T-cell Immunity
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.